- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 6)-iFluor® 350 Succinimidyl Ester
Anti-C5 MAb (Clone 6)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1090)
This product is comprised of an Human Anti-C5 IgG1-kappa (Clone 6) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Human Anti-C5 IgG1-kappa (Clone 6)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD4 MAb (Clone 27)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15002)
- Anti-CD4 MAb (Clone 7)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9817)
- Anti-CSF2 MAb (Clone 5)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16610)
- Anti-T-cell receptor MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS696)
- Anti-IGF1 MAb (Clone 4)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10511)
- Anti-TNFRSF9 MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6865)
- Anti-IFNA1 MAb (Clone 5)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7429)
- Anti-MS4A1 MAb (Clone 29)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS901)
- Anti-C-kit MAb (Clone 9)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9712)
- Anti-ERBB3 MAb (Clone 5)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16633)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS1090. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-738 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-735 | Anti-C5 (Pexelizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-729 | Anti-C5 (Eculizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.